FDA Offers New Guidance on Validating SARS-CoV-2 Tests in “Non-Laboratory” Settings by Glenn S. Demby | Aug 20, 2020 | Articles, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
Labs, Universities and Even Computer Companies Target Point-of-Care COVID-19 Test Development by Glenn S. Demby | Apr 1, 2020 | Deals-lir, Essential, Laboratory Industry Report... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
Laboratory Developed Tests: The VALID Act is Back by Glenn S. Demby | Mar 18, 2020 | Articles, CLIA-nir, Essential, Laboratory Industry Report, National Lab Reporter, News-nir... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
FDA Watch: Agency Finalizes CLIA Waiver Guidance for New IV Devices by Glenn S. Demby | Mar 6, 2020 | Essential, FDA-lir, Industry Buzz-lir, Laboratory Industry Report... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
Diagnostic Deals: Urgent Need for Coronavirus Diagnostics Fuels Strategic Collaboration by Glenn S. Demby | Mar 1, 2020 | Deals-lir, Essential, Laboratory Industry Report... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here